SARS News and Research

RSS

Genetic ancestry can explain population-level differences in immune response to the flu virus

A new study aimed at explaining differential susceptibility to viral epidemics reveals that ancestry and associated genetic variation can explain population-level differences in the immune response to the flu virus and perhaps also to COVID-19.

26 Nov 2021

Viral RNA in the blood found to be a reliable indicator of COVID-19 mortality risk

The amount of a SARS-CoV-2 genetic material-;viral RNA-;in the blood is a reliable indicator in detecting which patients will die of the disease, a team led by Université de Montréal medical professor Dr. Daniel Kaufmann has found.

26 Nov 2021

WHO designates Omicron (B.1.1.529) as SARS-CoV-2 Variant of Concern

The Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) is an independent group of experts that periodically monitors and evaluates the evolution of SARS-CoV-2 and assesses if specific mutations and combinations of mutations alter the behavior of the virus.

26 Nov 2021

Prediction of severe infection based on SARS-CoV-2 genomic analysis

A group of researchers have used these SARS-CoV-2 sequence data and developed an algorithm to predict severity based upon viral mutations.

26 Nov 2021

Multi-generational household clusters during COVID-19 pandemic in England

The research team aimed to validate a previous hypothesis on multi-generational households as a prime contributor to the overall number of COVID-19 cases during the Summer of 2020.

26 Nov 2021

Effects of social class, ethnicity, and gender on burden of COVID-19 mortality

The researchers determined if opportunities for remote work correlated with COVID-19 deaths for sociodemographic groups.

26 Nov 2021

Efficacy and safety of an RBD-based recombinant protein COVID-19 vaccine

A study developed a protein-based subunit vaccine, PHH-1V, that consisted of a recombinant RBD fusion heterodimer of the alpha) and beta variants of SARS-CoV-2.

26 Nov 2021

Antiviral activity of a photoactivable natural product on coronaviruses

A new study showed that pheophorbide a has antiviral activity against many CoVs.

26 Nov 2021

SARS-CoV-2 vaccine based on vesicular stomatitis virus exhibits high neutralizing efficacy against variants

Scientists have tested the efficacy of BriLife®-vaccinated human sera in neutralizing more infectious and probably more virulent SARS-CoV-2 variants.

26 Nov 2021

Post-discharge healthcare use of pediatric COVID-19 patients compared to pediatric RTIs patients

Researchers explored whether, and for how long, hospital contacts due to COVID-19 resulted in an increase in individual health care use, compared to hospital contacts with RSV infection and other RTIs.

26 Nov 2021

Discovering a new gene in monkeys that could help to develop new antivirals

We spoke to Dr. Nels Elde about his latest research that led to the discovery of a new gene in monkeys that could help to develop new antivirals.

26 Nov 2021

A review of natural immunity, vaccines, and variants in SARS-CoV-2 reinfection

In a literature review article published in the Journal of Community Hospital Internal Medicine Perspectives, authors from the US performed a thorough investigation of previous studies and case reports of SARS-CoV-2 reinfection. This review discusses the role of natural immunity, vaccines, and SARS-CoV-2 variants in reinfection.

25 Nov 2021

Triple combination symptoms anosmia-fatigue-cough more specific to COVID-19 than single symptoms

In a research paper published in the journal PLOS ONE, the authors developed COVID–Online, a symptom checking application in Germany.

25 Nov 2021

Study explores adverse effects of SARS-CoV-2-induced antibody responses

The authors of a research paper published in the journal Frontiers in Immunology used Sandwich ELISA tests to determine the distribution of IgG sub-classes and complement activation levels in plasma from convalescent individuals.

25 Nov 2021

Researchers reveal possible role for anti-idiotype antibodies in long-term effects of COVID-19

With around 256 million cases and more than 5 million deaths worldwide, the COVID-19 pandemic has challenged scientists and those in the medical field.

25 Nov 2021

Key to controlling COVID-19 is early intervention

A study published in the journal Royal Society Open Science demonstrates the critical role of timely intervention in New Zealand's success story. The researchers used a stochastic branching process model to simulate the trajectory of COVID-19 transmission and control during New Zealand's 2020 outbreak. They calculated the number of reported cases and deaths and the probability of elimination within a defined time frame.

25 Nov 2021

SARS News and Research

Genetic ancestry can explain population-level differences in immune response to the flu virus

Viral RNA in the blood found to be a reliable indicator of COVID-19 mortality risk

WHO designates Omicron (B.1.1.529) as SARS-CoV-2 Variant of Concern

Prediction of severe infection based on SARS-CoV-2 genomic analysis

Multi-generational household clusters during COVID-19 pandemic in England

Effects of social class, ethnicity, and gender on burden of COVID-19 mortality

Efficacy and safety of an RBD-based recombinant protein COVID-19 vaccine

Antiviral activity of a photoactivable natural product on coronaviruses

SARS-CoV-2 vaccine based on vesicular stomatitis virus exhibits high neutralizing efficacy against variants

Post-discharge healthcare use of pediatric COVID-19 patients compared to pediatric RTIs patients

Discovering a new gene in monkeys that could help to develop new antivirals

A review of natural immunity, vaccines, and variants in SARS-CoV-2 reinfection

Triple combination symptoms anosmia-fatigue-cough more specific to COVID-19 than single symptoms

Study explores adverse effects of SARS-CoV-2-induced antibody responses

Researchers reveal possible role for anti-idiotype antibodies in long-term effects of COVID-19

Key to controlling COVID-19 is early intervention

Using metal nanoparticles to fight SARS-CoV-2

What may the future hold in terms of SARS-CoV-2 variants?

COVID-19 vaccine boosters to prevent breakthrough SARS-CoV-2 infections in healthy adults

COVID-19 became more lethal in the U.K. in late 2020, statistical analysis suggests

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News